FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419291240> ?p ?o ?g. }

• W2419291240 endingPage "2663" @default.
• W2419291240 startingPage "2663" @default.
• W2419291240 abstract "Triptolide (TP) displays a strong immunosuppression function in immune-mediated diseases, especially in the treatment of rheumatoid arthritis. However, in addition to its medical and health-related functions, TP also exhibits diverse pharmacological side effects, for instance, liver and kidney toxicity and myelosuppression. In order to reduce the side effects, a nano drug carrier system (γ-PGA-l-PAE-TP [PPT]), in which TP was loaded by a poly-γ-glutamic acid-grafted l-phenylalanine ethylester copolymer, was developed. PPT was characterized by photon scattering correlation spectroscopy and transmission electron microscopy, which demonstrated that the average diameter of the drug carrier system is 98±15 nm, the polydispersity index is 0.18, the zeta potential is -35 mV, and the TP encapsulation efficiency is 48.6% with a controlled release manner. The methylthiazolyldiphenyl-tetrazolium bromide assay and flow cytometry revealed that PPT could decrease toxicity and apoptosis induced by free TP on RAW264.7 cells, respectively. The detection of reactive oxygen species showed that PPT could decrease the cellular reactive oxygen species induced by TP. Compared with the free TP-treated group, PPT improved the survival rate of the mice (P<0.01) and had no side effects or toxic effects on the thymus index (P>0.05) and spleen index (P>0.05). The blood biochemical indexes revealed that PPT did not cause much damage to the kidney (blood urea nitrogen and creatinine), liver (serum alanine aminotransferase and aspartate aminotransferase), or blood cells (P>0.05). Meanwhile, hematoxylin and eosin staining and terminal-deoxynucleotidyl transferase dUTP nick-end labeling staining indicated that PPT reduced the damage of free TP on the liver, kidney, and spleen. Our results demonstrated that PPT reduced free TP toxicity in vitro and in vivo and that it is a promising fundamental drug delivery system for rheumatoid arthritis treatment." @default.
• W2419291240 created "2016-06-24" @default.
• W2419291240 creator A5017623262 @default.
• W2419291240 creator A5024761367 @default.
• W2419291240 creator A5042278714 @default.
• W2419291240 creator A5065999911 @default.
• W2419291240 creator A5066716873 @default.
• W2419291240 creator A5069771802 @default.
• W2419291240 creator A5073498001 @default.
• W2419291240 creator A5086155499 @default.
• W2419291240 date "2016-06-01" @default.
• W2419291240 modified "2023-10-13" @default.
• W2419291240 title "Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo" @default.
• W2419291240 cites W108227102 @default.
• W2419291240 cites W1546481378 @default.
• W2419291240 cites W1834887465 @default.
• W2419291240 cites W1882935131 @default.
• W2419291240 cites W1903875142 @default.
• W2419291240 cites W1964986028 @default.
• W2419291240 cites W1969603156 @default.
• W2419291240 cites W1973474045 @default.
• W2419291240 cites W1974028927 @default.
• W2419291240 cites W1976592494 @default.
• W2419291240 cites W1983779246 @default.
• W2419291240 cites W1985201286 @default.
• W2419291240 cites W1988524540 @default.
• W2419291240 cites W1990492476 @default.
• W2419291240 cites W2011162627 @default.
• W2419291240 cites W2018480371 @default.
• W2419291240 cites W2022702812 @default.
• W2419291240 cites W2031378528 @default.
• W2419291240 cites W2032682839 @default.
• W2419291240 cites W2040513423 @default.
• W2419291240 cites W2044717523 @default.
• W2419291240 cites W2047894913 @default.
• W2419291240 cites W2055709375 @default.
• W2419291240 cites W2060208262 @default.
• W2419291240 cites W2067984761 @default.
• W2419291240 cites W2068138840 @default.
• W2419291240 cites W2074976827 @default.
• W2419291240 cites W2079966725 @default.
• W2419291240 cites W2084496503 @default.
• W2419291240 cites W2094601471 @default.
• W2419291240 cites W2104150259 @default.
• W2419291240 cites W2106398818 @default.
• W2419291240 cites W2111357501 @default.
• W2419291240 cites W2131551079 @default.
• W2419291240 cites W2142676369 @default.
• W2419291240 cites W2143660712 @default.
• W2419291240 cites W2155702314 @default.
• W2419291240 cites W2164912911 @default.
• W2419291240 cites W2170779256 @default.
• W2419291240 cites W225100285 @default.
• W2419291240 cites W2285407069 @default.
• W2419291240 cites W2314552137 @default.
• W2419291240 cites W2325552782 @default.
• W2419291240 cites W2337955099 @default.
• W2419291240 cites W2352579683 @default.
• W2419291240 cites W56747938 @default.
• W2419291240 cites W755401697 @default.
• W2419291240 cites W841521549 @default.
• W2419291240 doi "https://doi.org/10.2147/ijn.s104593" @default.
• W2419291240 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4907735" @default.
• W2419291240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27354796" @default.
• W2419291240 hasPublicationYear "2016" @default.
• W2419291240 type Work @default.
• W2419291240 sameAs 2419291240 @default.
• W2419291240 citedByCount "12" @default.
• W2419291240 countsByYear W24192912402017 @default.
• W2419291240 countsByYear W24192912402018 @default.
• W2419291240 countsByYear W24192912402020 @default.
• W2419291240 countsByYear W24192912402021 @default.
• W2419291240 countsByYear W24192912402022 @default.
• W2419291240 countsByYear W24192912402023 @default.
• W2419291240 crossrefType "journal-article" @default.
• W2419291240 hasAuthorship W2419291240A5017623262 @default.
• W2419291240 hasAuthorship W2419291240A5024761367 @default.
• W2419291240 hasAuthorship W2419291240A5042278714 @default.
• W2419291240 hasAuthorship W2419291240A5065999911 @default.
• W2419291240 hasAuthorship W2419291240A5066716873 @default.
• W2419291240 hasAuthorship W2419291240A5069771802 @default.
• W2419291240 hasAuthorship W2419291240A5073498001 @default.
• W2419291240 hasAuthorship W2419291240A5086155499 @default.
• W2419291240 hasBestOaLocation W24192912401 @default.
• W2419291240 hasConcept C150903083 @default.
• W2419291240 hasConcept C178790620 @default.
• W2419291240 hasConcept C185592680 @default.
• W2419291240 hasConcept C190283241 @default.
• W2419291240 hasConcept C207001950 @default.
• W2419291240 hasConcept C2778176769 @default.
• W2419291240 hasConcept C2780306776 @default.
• W2419291240 hasConcept C2781164371 @default.
• W2419291240 hasConcept C29730261 @default.
• W2419291240 hasConcept C55493867 @default.
• W2419291240 hasConcept C86803240 @default.
• W2419291240 hasConcept C98274493 @default.
• W2419291240 hasConceptScore W2419291240C150903083 @default.
• W2419291240 hasConceptScore W2419291240C178790620 @default.

• next